BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 35280794)

  • 1. The Value of Serum Tumor Markers and Blood Inflammation Markers in Differentiating Pancreatic Serous Cystic Neoplasms and Pancreatic Mucinous Cystic Neoplasms.
    Wang H; Chen S; Shu X; Liu Z; Liu P; Zhu Y; Zhu Y; Xiong H
    Front Oncol; 2022; 12():831355. PubMed ID: 35280794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CT classification model of pancreatic serous cystic neoplasms and mucinous cystic neoplasms based on a deep neural network.
    Yang R; Chen Y; Sa G; Li K; Hu H; Zhou J; Guan Q; Chen F
    Abdom Radiol (NY); 2022 Jan; 47(1):232-241. PubMed ID: 34636931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiparameter Analysis Using
    Wang G; Dang H; Yu P; Liu H; Wu Y; Yao S; Tian J; Ye H; Xu B
    Contrast Media Mol Imaging; 2021; 2021():6658644. PubMed ID: 33880111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreatic serous oligocystic adenomas: clinicopathologic features and a comparison with serous microcystic adenomas and mucinous cystic neoplasms.
    Goh BK; Tan YM; Yap WM; Cheow PC; Chow PK; Chung YF; Wong WK; Ooi LL
    World J Surg; 2006 Aug; 30(8):1553-9. PubMed ID: 16773248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of cyst fluid CEA and CA 125 is an accurate diagnostic tool for differentiating mucinous cystic neoplasms from intraductal papillary mucinous neoplasms.
    Nagashio Y; Hijioka S; Mizuno N; Hara K; Imaoka H; Bhatia V; Niwa Y; Tajika M; Tanaka T; Ishihara M; Shimizu Y; Hosoda W; Yatabe Y; Yamao K
    Pancreatology; 2014; 14(6):503-9. PubMed ID: 25458668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suboptimal accuracy of carcinoembryonic antigen in differentiation of mucinous and nonmucinous pancreatic cysts: results of a large multicenter study.
    Gaddam S; Ge PS; Keach JW; Mullady D; Fukami N; Edmundowicz SA; Azar RR; Shah RJ; Murad FM; Kushnir VM; Watson RR; Ghassemi KF; Sedarat A; Komanduri S; Jaiyeola DM; Brauer BC; Yen RD; Amateau SK; Hosford L; Hollander T; Donahue TR; Schulick RD; Edil BH; McCarter M; Gajdos C; Attwell A; Muthusamy VR; Early DS; Wani S
    Gastrointest Endosc; 2015 Dec; 82(6):1060-9. PubMed ID: 26077458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyst fluid analysis in the differential diagnosis of pancreatic cysts. A comparison of pseudocysts, serous cystadenomas, mucinous cystic neoplasms, and mucinous cystadenocarcinoma.
    Lewandrowski KB; Southern JF; Pins MR; Compton CC; Warshaw AL
    Ann Surg; 1993 Jan; 217(1):41-7. PubMed ID: 8424699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective study on endoscopic ultrasound for the differential diagnosis of serous cystic neoplasms and mucinous cystic neoplasms.
    Zhong L; Chai N; Linghu E; Li H; Yang J; Tang P
    BMC Gastroenterol; 2019 Jul; 19(1):127. PubMed ID: 31311499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cystic Neoplasms of the Pancreas: Differential Diagnosis and Radiology Correlation.
    Hu F; Hu Y; Wang D; Ma X; Yue Y; Tang W; Liu W; Wu P; Peng W; Tong T
    Front Oncol; 2022; 12():860740. PubMed ID: 35299739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreatic Serous Cystic Neoplasms and Mucinous Cystic Neoplasms: Differential Diagnosis by Combining Imaging Features and Enhanced CT Texture Analysis.
    Chen HY; Deng XY; Pan Y; Chen JY; Liu YY; Chen WJ; Yang H; Zheng Y; Yang YB; Liu C; Shao GL; Yu RS
    Front Oncol; 2021; 11():745001. PubMed ID: 35004272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation and management of hepatobiliary mucinous cystic neoplasms: a single centre experience for 8 years.
    Gao J; Zheng J; Cai J; Kirih MA; Xu J; Tao L; Liang Y; Feng X; Fang J; Liang X
    BMC Surg; 2021 Mar; 21(1):146. PubMed ID: 33743655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential diagnosis of cystic tumors of the pancreas by endoscopic ultrasonography.
    Kubo H; Nakamura K; Itaba S; Yoshinaga S; Kinukawa N; Sadamoto Y; Ito T; Yonemasu H; Takayanagi R
    Endoscopy; 2009 Aug; 41(8):684-9. PubMed ID: 19670136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of serum tumor biomarkers in predicting advanced cystic mucinous neoplasm of the pancreas.
    Sun LQ; Peng LS; Guo JF; Jiang F; Cui F; Huang HJ; Jin ZD
    World J Gastroenterol; 2021 Feb; 27(6):501-512. PubMed ID: 33642824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The value of systemic inflammatory markers in identifying malignancy in mucinous pancreatic cystic neoplasms.
    Zhou W; Rong Y; Kuang T; Xu Y; Shen X; Ji Y; Lou W; Wang D
    Oncotarget; 2017 Dec; 8(70):115561-115569. PubMed ID: 29383181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-Phase CT-Based Radiomics Nomogram for Discrimination Between Pancreatic Serous Cystic Neoplasm From Mucinous Cystic Neoplasm.
    Gao J; Han F; Wang X; Duan S; Zhang J
    Front Oncol; 2021; 11():699812. PubMed ID: 34926238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential diagnosis of pancreatic serous oligocystic adenoma and mucinous cystic neoplasm with spectral CT imaging: initial results.
    Lin XZ; Wu ZY; Li WX; Zhang J; Xu XQ; Chen KM; Yan FH
    Clin Radiol; 2014 Oct; 69(10):1004-10. PubMed ID: 24919983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Preoperative Risk Factors With Malignancy in Pancreatic Mucinous Cystic Neoplasms: A Multicenter Study.
    Postlewait LM; Ethun CG; McInnis MR; Merchant N; Parikh A; Idrees K; Isom CA; Hawkins W; Fields RC; Strand M; Weber SM; Cho CS; Salem A; Martin RC; Scoggins C; Bentrem D; Kim HJ; Carr J; Ahmad S; Abbott DE; Wilson GC; Kooby DA; Maithel SK
    JAMA Surg; 2017 Jan; 152(1):19-25. PubMed ID: 27760255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic cystic neoplasms: a review of preoperative diagnosis and management.
    Bai XL; Zhang Q; Masood N; Masood W; Zhang Y; Liang TB
    J Zhejiang Univ Sci B; 2013 Mar; 14(3):185-94. PubMed ID: 23463761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic value of combining preoperative inflammatory markers ratios with CA199 for patients with early-stage pancreatic cancer.
    Gu Y; Hua Q; Li Z; Zhang X; Lou C; Zhang Y; Wang W; Cai P; Zhao J
    BMC Cancer; 2023 Mar; 23(1):227. PubMed ID: 36899319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential diagnosis of pancreatic cystic neoplasms through a radiomics-assisted system.
    Dong Z; Chen X; Cheng Z; Luo Y; He M; Chen T; Zhang Z; Qian X; Chen W
    Front Oncol; 2022; 12():941744. PubMed ID: 36591475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.